Display options
Share it on

Rev Clin Esp (Barc). 2020 Nov;220(8):534-536. doi: 10.1016/j.rce.2020.04.012. Epub 2020 May 04.

[Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids].

Revista clinica espanola

[Article in Spanish]
J Varona Pérez, J M Rodriguez Chinesta

Affiliations

  1. Servicio de Medicina Interna, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España. Electronic address: [email protected].
  2. Servicio de Medicina Interna, Hospital Universitario de Cruces, Baracaldo, Vizcaya, España.

PMID: 32372768 PMCID: PMC7198170 DOI: 10.1016/j.rce.2020.04.012

[No abstract available.]

References

  1. Med J Aust. 2020 May;212(9):416-420 - PubMed
  2. RMD Open. 2020 Feb;6(1): - PubMed
  3. Int J Rheum Dis. 2017 Jul;20(7):859-869 - PubMed
  4. Gastroenterology. 2017 May;152(6):1297-1309 - PubMed
  5. J Hepatol. 2017 Aug;67(2):370-398 - PubMed
  6. J Hepatol. 2020 Jan;72(1):57-66 - PubMed

Publication Types